Rapid Micro shares rise 21.05% after-hours on 37% Q4 revenue growth to $11.3 million.
ByAinvest
Wednesday, Jan 14, 2026 4:51 pm ET1min read
RPID--
Rapid Micro Biosystems (NASDAQ:RPID) surged 21.05% in after-hours trading following a report of 37% year-over-year revenue growth in Q4 2025, with the company projecting approximately $11.3 million in total revenue for the quarter. The strong revenue performance highlights momentum in its diagnostic testing solutions and partnerships, reinforcing investor confidence in the firm’s market expansion and operational scalability.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet